Phase-I trial of combination chemotherapy and donor lymphocyte infusion for relapsed aggressive hematologic malignancies following allogeneic bone marrow transplantation.

被引:0
|
作者
Mookerjee, B
Couzi, R
Seber, A
Miller, C
Noga, S
Douglas, T
Altomonte, V
Gore, S
Jones, R
Vogelsang, G
Fuchs, E
机构
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
708
引用
收藏
页码:162A / 162A
页数:1
相关论文
共 50 条
  • [41] A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
    Davids, Matthew S.
    Kim, Haesook T.
    Costello, Caitlin L.
    Herrera, Alex F.
    Locke, Frederick L.
    Maegawa, Rodrigo O.
    Savell, Alexandra
    Mazzeo, Michael
    Avigan, David E.
    Chen, Yi-Bin
    Nikiforow, Sarah
    Ho, Vincent T.
    Cutler, Corey S.
    Alyea, Edwin P., III
    Bachireddy, Pavan
    Wu, Catherine J.
    Streicher, Howard
    Ball, Edward D.
    Bashey, Asad
    Soiffer, Robert J.
    Armand, Philippe
    BLOOD, 2018, 132
  • [42] A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
    Ghobadi, Armin
    Fiala, Mark A.
    Abboud, Camille N.
    Cashen, Amanda F.
    Eissenberg, Linda
    Graubert, Timothy
    Jacoby, Meagan A.
    Pusic, Iskra
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Tomasson, Michael H.
    Uy, Geoffrey L.
    Vij, Ravi
    Walter, Matthew J.
    DiPersio, John F.
    Westervelt, Peter
    BLOOD, 2013, 122 (21)
  • [43] Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation
    J Ishikawa
    T Maeda
    H Kashiwagi
    H Yoshida
    I Takahashi
    S-I Kawamoto
    M Yamada
    H Kato
    T Nishiura
    Y Tomiyama
    Y Matsuzawa
    Bone Marrow Transplantation, 2003, 31 : 1057 - 1059
  • [44] A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplantation
    Inamoto, Yoshihiro
    Fefer, Alexander
    Sandmaier, Brenda M.
    Gooley, Theodore A.
    Warren, Edus H.
    Petersdorf, Stephen H.
    Sanders, Jean E.
    Storb, Rainer F.
    Appelbaum, Frederick R.
    Martin, Paul J.
    Flowers, Mary E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (09) : 1308 - 1315
  • [45] A PHASE I/II STUDY OF CHEMOTHERAPY FOLLOWED BY DONOR LYMPHOCYTE INFUSION PLUS INTERLEUKIN-2 FOR RELAPSED ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Inamoto, Y.
    Fefer, A.
    Sandmaier, B. M.
    Gooley, T. A.
    Warren, E. H.
    Petersdorf, S. H.
    Sanders, J. E.
    Storb, R. F.
    Appelbaum, F. R.
    Martin, P. J.
    Flowers, M. E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S339 - S339
  • [46] Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation
    Ishikawa, J
    Maeda, T
    Kashiwagi, H
    Yoshida, H
    Takahashi, I
    Kawamoto, SI
    Yamada, M
    Kato, H
    Nishiura, T
    Tomiyama, Y
    Matsuzawa, Y
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 1057 - 1059
  • [47] Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation
    Lee, JH
    Lee, KH
    Kim, S
    Seol, M
    Kim, SH
    Kim, WK
    Lee, JS
    LEUKEMIA RESEARCH, 2001, 25 (04) : 305 - 312
  • [48] a Phase I Trial of Bendamustine in Combination with Clofarabine and Etoposide in Pediatric Patients with Relapsed or Refractory Hematologic Malignancies
    Jeha, Sima
    Metzger, Monika L.
    Crews, Kristine R.
    Campbell, Patrick
    Ribeiro, Raul C.
    Cheng, Cheng
    Peyton, Melissa
    Panetta, Carl
    Yang, Jun
    Pui, Ching-Hon
    Bhojwani, Deepa
    BLOOD, 2016, 128 (22)
  • [49] Treatment of relapsed acute myeloid leukaemia after allogeneic bone marrow transplantation with combination chemotherapy of cytarabine, idarubicin plus etoposide and subsequent donor leukocyte infusion: a prospective study
    Choi, SJ
    Lee, JH
    Lee, JH
    Kim, S
    Seol, M
    Lee, YS
    Lee, JS
    Kim, WK
    Lee, KH
    BONE MARROW TRANSPLANTATION, 2004, 33 : S232 - S233
  • [50] DECITABINE IN COMBINATION WITH DONOR LYMPHOCYTE INFUSION AS SALVAGE THERAPY FOR RELAPSED AML POST-ALLOGENEIC STEM CELL TRANSPLANTATION
    Kritharis, A.
    Donahue, L. L.
    Keyzner, A.
    Devoe, C.
    Bayer, R. L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S327 - S327